Epstein-Barr病毒胸苷激酶（TK）基因表达质粒的构建

目的：构建高效表达EBVTK的重组克隆体系。方法：以pUC8X为模板，5'-CTGAATTCATG—GCTGGATTTCC-3’及5’CAACTGCAGCCTAGTCCCGATT-3’为引物，用PCR技术扩增出EBVtk基因的DNA片段。EcoR I／Pst I双酶切PCR产物和载体pBV220，T4连接酶使目的基因tk定向克隆至选定质粒pBV220中。结果：重组质粒pBV220-tk经EcoR I／Pst I双酶切后得两条电泳带分别位于1．8kb、3．6kb处；以pBV220-tk为模板，两引物同上进行PCR扩增，产物电泳带于1．8kb处。结论：目的基因tk已定向克隆至质粒pBV220中。     

子宫内膜癌CD44v6的表达及意义

目的:研究子宫内膜癌的CD44v6的表达与子宫内膜癌浸润转移的关系。方法:应用免疫组织化学SP法检测50例子宫内膜 癌的CD44v6的表达情况。结果:在有淋巴结转移组中,CD44v6阳性表达率明显低于无淋巴结转移组(P<0.05),但其与子宫内膜癌的 组织学类型、病理分级、临床分期及癌组织浸润肌层深度无关。结论: CD44v6的低表达可促进子宫内膜癌的淋巴结转移。     

Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study

Renal carcinomas (RC) are uncommonly encountered in feline medicine. Limited information regarding clinical presentation and postoperative outcomes is available. The purpose of this multi-institutional, retrospective study was to describe the presenting features and clinical outcomes of cats with RC undergoing nephrectomy. Thirty-six client-owned cats were included. Medical records from participating institutions were searched to identify cats that had a histopathologic diagnosis of RC and underwent nephrectomy from January 2001 to October 2021. The most common presenting complaints were weight loss (36.1%) and hyporexia (30.6%). Based on preoperative imaging and intraoperative findings, eight cats had suspected metastasis at the time of surgery (22.2%). Twenty-eight cats survived to discharge (77.8%). Median progression free interval (PFI) could not be determined, as only six cats developed suspected recurrence (16.7%) and seven cats developed suspected metastasis (19.4%). The all-cause median survival time (MST) was 203 days (95% confidence interval [CI]: 84, 1379 days). When cases that died prior to discharge were excluded, MST increased to 1217 days (95% CI: 127, 1641 days). One-year, two-year, and three-year survival rates were all 40.4%. Neither renal tumour histologic subtype nor the presence of preoperative azotemia, anaemia, erythrocytosis, haematuria, or suspected metastasis at diagnosis were found to influence survival. For cats surviving to discharge, prolonged survival times were possible. Further studies are necessary to elucidate other potential prognostic factors, the utility of postoperative adjuvant treatment, and to identify cats at-risk of mortality in the perioperative period.